These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 211041)

  • 1. Caffeine elicited withdrawal signs in morphine-dependent rhesus monkeys.
    Aceto MD; Carchman RA; Harris LS; Flora RE
    Eur J Pharmacol; 1978 Aug; 50(3):203-7. PubMed ID: 211041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of naloxone and nalorphine during the development of morphine dependence in rhesus monkeys.
    Aceto MD; Flora RE; Harris LS
    Pharmacology; 1977; 15(1):1-9. PubMed ID: 402658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of quasi-morphine withdrawal behaviour induced by methylxanthines.
    Butt NM; Collier HO; Cuthbert NJ; Francis DL; Saeed SA
    Eur J Pharmacol; 1979 Feb; 53(4):375-8. PubMed ID: 217699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of cyclic AMP-specific phosphodiesterase 4 activation during naloxone-precipitated morphine withdrawal in rats.
    Kimura M; Tokumura M; Itoh T; Inoue O; Abe K
    Neurosci Lett; 2006 Aug; 404(1-2):107-11. PubMed ID: 16753260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naltrexone effects on morphine and food self-administration in morphine-dependent rhesus monkeys.
    Mello NK; Mendelson JH; Bree MP
    J Pharmacol Exp Ther; 1981 Aug; 218(2):550-7. PubMed ID: 7195937
    [No Abstract]   [Full Text] [Related]  

  • 6. Conditioned behavioral and physiological changes associated with injections of a narcotic antagonist in morphine-dependent monkeys.
    Goldberg SR
    Pavlov J Biol Sci; 1976; 11(4):203-21. PubMed ID: 825815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of opioid agonists in maintaining responding and in suppressing morphine withdrawal in rhesus monkeys.
    Young AM; Swain HH; Woods JH
    Psychopharmacology (Berl); 1981; 74(4):329-35. PubMed ID: 6794076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of morphine, naloxone, buprenorphine, butorphanol, haloperidol and imipramine on morphine withdrawal signs in cynomolgus monkeys.
    Fukase H; Fukuzaki K; Koja T; Nagata R; Lukas SE
    Psychopharmacology (Berl); 1994 Dec; 116(4):396-400. PubMed ID: 7701039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. l-theanine attenuates abstinence signs in morphine-dependent rhesus monkeys and elicits anxiolytic-like activity in mice.
    Wise LE; Premaratne ID; Gamage TF; Lichtman AH; Hughes LD; Harris LS; Aceto MD
    Pharmacol Biochem Behav; 2012 Dec; 103(2):245-52. PubMed ID: 22935630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The opiate quasiwithdrawal syndrome in rhesus monkeys: comparison of naloxone-precipitated withdrawal to effects of cholinergic agents.
    Katz JL; Valentino RJ
    Psychopharmacology (Berl); 1984; 84(1):12-5. PubMed ID: 6436878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of beta-funaltrexamine in normal and morphine-dependent rhesus monkeys: observational studies.
    Gmerek DE; Woods JH
    J Pharmacol Exp Ther; 1985 Nov; 235(2):296-301. PubMed ID: 4057071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nalorphine: increased sensitivity of monkeys formerly dependent on morphine.
    Goldberg SR; Schuster CR
    Science; 1969 Dec; 166(3912):1548-9. PubMed ID: 17655059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The actions of narcotic antagonists in morphine-dependent rhesus monkeys.
    Villarreal JE; Karbowski MG
    Adv Biochem Psychopharmacol; 1973; 8(0):273-89. PubMed ID: 4212386
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug dependence potential of viloxazine hydrochloride tested in rhesus monkeys.
    Yanagita T; Wakasa Y; Kiyohara H
    Pharmacol Biochem Behav; 1980 Jan; 12(1):155-61. PubMed ID: 6768070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug dependence potential of 1-(m-methoxyphenyl)-2-dimethylaminomethyl)-cyclohexan-1-ol hydrochloride (tramadol) tested in monkeys.
    Yanagita T
    Arzneimittelforschung; 1978; 28(1a):158-63. PubMed ID: 415747
    [No Abstract]   [Full Text] [Related]  

  • 16. Opiates, cyclic nucleotides, and xanthines.
    Collier HO; Francis DL; Roy AC
    Adv Biochem Psychopharmacol; 1976; 15():337-45. PubMed ID: 192053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Termination of a schedule complex associated with intravenous injections of nalorphine in morphine-dependent rhesus monkeys.
    Tang AH; Morse WH
    Pharmacol Rev; 1975 Sep; 27(3):407-17. PubMed ID: 817311
    [No Abstract]   [Full Text] [Related]  

  • 18. Involvement of cyclic AMP systems in morphine physical dependence in mice: prevention of development of morphine dependence by rolipram, a phosphodiesterase 4 inhibitor.
    Mamiya T; Noda Y; Ren X; Hamdy M; Furukawa S; Kameyama T; Yamada K; Nabeshima T
    Br J Pharmacol; 2001 Mar; 132(5):1111-7. PubMed ID: 11226142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Character and meaning of quasi-morphine withdrawal phenomena elicited by methylxanthines.
    Collier HO; Cuthbert NJ; Francis DL
    Fed Proc; 1981 Apr; 40(5):1513-8. PubMed ID: 6163662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of propranolol on antinociceptive, tolerance- and dependence-producing properties of morphine in rodents and monkeys.
    Cowan A; Macfarlane IR
    Eur J Pharmacol; 1975 Nov; 34(1):87-94. PubMed ID: 11999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.